Jeffrey T. Walsh

2019

In 2019, Jeffrey T. Walsh earned a total compensation of $5.3M as Former Chief Strategy Officer at bluebird bio, a 43% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$206,213
Option Awards$2,935,690
Salary$470,000
Stock Awards$1,136,008
Other$510,246
Total$5,258,157

Walsh received $2.9M in option awards, accounting for 56% of the total pay in 2019.

Walsh also received $206.2K in non-equity incentive plan, $470K in salary, $1.1M in stock awards and $510.2K in other compensation.

Rankings

In 2019, Jeffrey T. Walsh's compensation ranked 2,058th out of 13,971 executives tracked by ExecPay. In other words, Walsh earned more than 85.3% of executives.

ClassificationRankingPercentile
All
2,058
out of 13,971
85th
Division
Manufacturing
748
out of 5,692
87th
Major group
Chemicals And Allied Products
226
out of 2,189
90th
Industry group
Drugs
183
out of 1,875
90th
Industry
Biological Products, Except Diagnostic Substances
47
out of 389
88th
Source: SEC filing on April 27, 2020.

Walsh's colleagues

We found five more compensation records of executives who worked with Jeffrey T. Walsh at bluebird bio in 2019.

2019

Nick Leschly

bluebird bio

Chief Executive Officer

2019

William Baird

bluebird bio

Chief Financial Officer

2019

David Davidson

bluebird bio

Chief Medical Officer

2019

Philip Gregory

bluebird bio

Chief Scientific Officer

2019

Jason Cole

bluebird bio

Chief Operating and Legal Officer

News

In-depth

You may also like